KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, discovers, develops, and markets small-molecule protease inhibitors for illnesses with unmet needs. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
KALV Price Trend and Signals
KALV Option Volumes & Open Interests (aggregated)
KALV Put Call Ratios and IV (aggregated)
2025-08-28Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-08-28Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-08-28Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-08-28Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.